These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 15620474)
1. Validation of self-reported pneumococcal vaccination in behavioral risk factor surveillance surveys: experience from the sickness prevention achieved through regional collaboration (SPARC) program. Shenson D; Dimartino D; Bolen J; Campbell M; Lu PJ; Singleton JA Vaccine; 2005 Jan; 23(8):1015-20. PubMed ID: 15620474 [TBL] [Abstract][Full Text] [Related]
2. Influenza and pneumococcal vaccination in older veterans: results from the behavioral risk factor surveillance system. Chi RC; Reiber GE; Neuzil KM J Am Geriatr Soc; 2006 Feb; 54(2):217-23. PubMed ID: 16460371 [TBL] [Abstract][Full Text] [Related]
3. An emergency department-based vaccination program: overcoming the barriers for adults at high risk for vaccine-preventable diseases. Rimple D; Weiss SJ; Brett M; Ernst AA Acad Emerg Med; 2006 Sep; 13(9):922-30. PubMed ID: 16902048 [TBL] [Abstract][Full Text] [Related]
4. Differences in attitudes, beliefs and knowledge of hospital health care workers and community doctors to vaccination of older people. Ridda I; Lindley IR; Gao Z; McIntyre P; Macintyre CR Vaccine; 2008 Oct; 26(44):5633-40. PubMed ID: 18706955 [TBL] [Abstract][Full Text] [Related]
5. Influenza and pneumococcal vaccination rates among smokers: data from the 2006 Behavioral Risk Factor Surveillance System. Pearson WS; Dube SR; Ford ES; Mokdad AH Prev Med; 2009 Feb; 48(2):180-3. PubMed ID: 19041339 [TBL] [Abstract][Full Text] [Related]
6. Validity of self-reported pneumococcal vaccination status in the elderly in Spain. Bayas JM; Izquierdo C; Ruiz L; Sintes X; Sousa D; Celorrio JM; Varona W; Carratalà J; Nebot M; Batalla J; Sugrañes S; Manzur A; Terren A; García C; Clemente E; Rivera S; Justo I; Arévalo A; Salleras L; Domínguez A Vaccine; 2009 Jul; 27(34):4560-4. PubMed ID: 19508910 [TBL] [Abstract][Full Text] [Related]
7. Adults with invasive pneumococcal disease: missed opportunities for vaccination. Kyaw MH; Greene CM; Schaffner W; Ray SM; Shapiro M; Barrett NL; Gershman K; Craig AS; Roberson A; Zell ER; Schuchat A; Bennett NM; Whitney CG; Am J Prev Med; 2006 Oct; 31(4):286-92. PubMed ID: 16979452 [TBL] [Abstract][Full Text] [Related]
9. Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease--United States, 1998-2003. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2005 Sep; 54(36):893-7. PubMed ID: 16163262 [TBL] [Abstract][Full Text] [Related]
10. Validity and reliability of self-reported arthritis: Georgia senior centers, 2000-2001. Bombard JM; Powell KE; Martin LM; Helmick CG; Wilson WH Am J Prev Med; 2005 Apr; 28(3):251-8. PubMed ID: 15766612 [TBL] [Abstract][Full Text] [Related]
11. Influenza and pneumococcal vaccination coverage among persons aged > or = 65 years--United States, 2004-2005. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2006 Oct; 55(39):1065-8. PubMed ID: 17021591 [TBL] [Abstract][Full Text] [Related]
12. HHS-CDC news: Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease--US, 1998-2003. Ann Pharmacother; 2005 Nov; 39(11):1967-8. PubMed ID: 16219891 [No Abstract] [Full Text] [Related]
13. Impact of pediatric vaccination with pneumococcal conjugate vaccine on the risk of bacteremic pneumococcal pneumonia in adults. Metlay JP; Fishman NO; Joffe M; Edelstein PH Vaccine; 2006 Jan; 24(4):468-75. PubMed ID: 16125826 [TBL] [Abstract][Full Text] [Related]
14. Changing epidemiology of invasive pneumococcal disease among White Mountain Apache persons in the era of the pneumococcal conjugate vaccine. Lacapa R; Bliss SJ; Larzelere-Hinton F; Eagle KJ; McGinty DJ; Parkinson AJ; Santosham M; Craig MJ; O'Brien KL Clin Infect Dis; 2008 Aug; 47(4):476-84. PubMed ID: 18627249 [TBL] [Abstract][Full Text] [Related]
15. Epidemiologic features of invasive pneumococcal disease in Belgian children: passive surveillance is not enough. Vergison A; Tuerlinckx D; Verhaegen J; Malfroot A; Pediatrics; 2006 Sep; 118(3):e801-9. PubMed ID: 16894008 [TBL] [Abstract][Full Text] [Related]
16. Reduction in the incidence of invasive pneumococcal disease after general vaccination with 7-valent pneumococcal conjugate vaccine in Germany. Rückinger S; van der Linden M; Reinert RR; von Kries R; Burckhardt F; Siedler A Vaccine; 2009 Jun; 27(31):4136-41. PubMed ID: 19406190 [TBL] [Abstract][Full Text] [Related]
17. Effectiveness of the 7-valent pneumococcal conjugate vaccine in children with sickle cell disease in the first decade of life. Adamkiewicz TV; Silk BJ; Howgate J; Baughman W; Strayhorn G; Sullivan K; Farley MM Pediatrics; 2008 Mar; 121(3):562-9. PubMed ID: 18310206 [TBL] [Abstract][Full Text] [Related]
18. Assessment of vaccine coverage following the introduction of a publicly funded pneumococcal vaccine program for the elderly in Victoria, Australia. Andrews RM Vaccine; 2005 Apr; 23(21):2756-61. PubMed ID: 15780723 [TBL] [Abstract][Full Text] [Related]
19. Validity of self-reported influenza and pneumococcal vaccination status among a cohort of hospitalized elderly inpatients. Skull SA; Andrews RM; Byrnes GB; Kelly HA; Nolan TM; Brown GV; Campbell DA Vaccine; 2007 Jun; 25(25):4775-83. PubMed ID: 17499402 [TBL] [Abstract][Full Text] [Related]
20. Effectiveness of a 2+1 dose schedule pneumococcal conjugate vaccination programme on invasive pneumococcal disease among children in Norway. Vestrheim DF; Løvoll O; Aaberge IS; Caugant DA; Høiby EA; Bakke H; Bergsaker MR Vaccine; 2008 Jun; 26(26):3277-81. PubMed ID: 18456376 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]